Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 133 500 KRW -1.33% Market Closed
Market Cap: 1.5T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Daewoong Pharma
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daewoong Pharma
Cash from Financing Activities Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Daewoong Pharma
KRX:069620
Cash from Financing Activities
â‚©130.8B
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
15%
Yuhan Corp
KRX:000100
Cash from Financing Activities
â‚©90B
CAGR 3-Years
104%
CAGR 5-Years
N/A
CAGR 10-Years
15%
SK Biopharmaceuticals Co Ltd
KRX:326030
Cash from Financing Activities
â‚©6.6B
CAGR 3-Years
-77%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Cash from Financing Activities
-â‚©76.3B
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Cash from Financing Activities
â‚©21.3B
CAGR 3-Years
-23%
CAGR 5-Years
8%
CAGR 10-Years
N/A
C
Celltrion Pharm Inc
KOSDAQ:068760
Cash from Financing Activities
-â‚©14.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Daewoong Pharma's Cash from Financing Activities?
Cash from Financing Activities
130.8B KRW

Based on the financial report for Jun 30, 2024, Daewoong Pharma's Cash from Financing Activities amounts to 130.8B KRW.

What is Daewoong Pharma's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
15%

Over the last year, the Cash from Financing Activities growth was 491%. The average annual Cash from Financing Activities growth rates for Daewoong Pharma have been 9% over the past three years , and 15% over the past ten years .

Back to Top